UNSPSC 51422325: Betamethasone butyrate propionate

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H39FO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50FH5AG9RW, chemically known as 9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)- but more generally known as betamethasone butyrate propionate, which bears US NIH Compound Identifier 71470.

UNSPSC 51422325 Betamethasone butyrate propionate is a Commodity code that, based on recent state and local solicitation activity, does not align with the pharmaceutical products actually being procured under this designation. The recent opportunity on record—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—falls outside the scope of a corticosteroid pharmaceutical. State and local governments use UNSPSC codes to classify procurement across health and safety supplies, but this code shows little relevant recent activity that matches its nominal scope of a specific topical steroid formulation.

Seminole County posted the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement is a standard competitive bid with standard commercial terms—fixed-fee pricing, two-year initial term with one-year renewal option, E-Verify compliance, and standard insurance requirements. FEMA potential funding introduces compliance with the Clean Air Act and Federal Water Pollution Control Act. The absence of documented recent opportunities aligned with the code's stated pharmaceutical product suggests this Commodity code may see limited or misclassified state and local procurement activity currently.